Repro Med Systems (NASDAQ: KRMD) — Perfil da empresa, notícias e dados financeiros
Repro Med Systems designs innovative devices for subcutaneous drug delivery in home healthcare.

Repro Med Systems
Repro Med Systems, also known colloquially as KORU Medical Systems (NASDAQ:KRMD), specializes in the design, manufacture, and marketing of innovative medical devices for the home healthcare market. The company is dedicated to improving the lives of patients by offering products that focus on subcutaneous drug delivery for chronic conditions, enabling users to manage their treatments more comfortably and effectively outside of a clinical setting. KORU Medical Systems is committed to advancing healthcare by expanding its product line, leveraging cutting-edge technology to meet the evolving needs of patients, and ensuring high-quality and accessible medical solutions. Its main objectives include enhancing patient care, driving innovation in home healthcare solutions, and expanding its market presence globally through strategic partnerships and product development.
Resumo
Operações
Produtos e/ou serviços de Repro Med Systems
- FREEDOM60 and FREEDOMEdge Syringe Infusion Systems, designed for safe, portable medication delivery.
- Precision Flow Rate Tubing and HIgH-Flo Subcutaneous Safety Needle Sets, enhancing infusion accuracy and patient comfort.
- Freedom Flow Rate Calculator, a tool aiding clinicians in prescribing accurate infusion rates.
- RES-Q-VAC, a portable, manual suction system used for airway clearance.
- Easy-Load Syringe Pump Sets, tailored for simplicity and efficiency in various infusion therapies.
- Training and educational programs for healthcare providers and patients, ensuring effective use of their infusion products.
equipe executiva do Repro Med Systems
- Adam KalbermattenPresident & CEO
- Thomas AdamsCFO, Secretary & Treasurer
- Christopher PazdanChief Operating Officer
- Eric SchillerChief Technology Officer
Últimas notícias sobre a Repro Med Systems
Principais indicadores financeiros
Resultados divulgados pela Repro Med Systems, em USD.
- Cap. de mercado
- 145,6 mi
- Receita (TTM)
- 45,1 mi
- P/L
- —
- LPA (diluído, TTM)
- -0.0
- Dividend yield
- —
- Margem de lucro
- -4.0%
| Fim do ano fiscal | Receita | Resultado operacional | Lucro líquido |
|---|---|---|---|
| 41,1 mi | -3 mi | -2,6 mi | |
| 33,6 mi | -6,4 mi | -6,1 mi | |
| 28,5 mi | -10,3 mi | -13,7 mi | |
| 27,9 mi | -10,8 mi | -8,7 mi |